Back to search results

Intervention for Young Adults with Cancer and Their Partners

This study is testing a behavioral intervention called "Young Adults Coping with Cancer Together Intervention" for young adults (ages 25-39) with cancer and their partners who provide care. This intervention combines cognitive-behavioral therapy and couples' therapy to help improve coping skills, self-confidence in managing cancer and caregiving, and maintain relationships. The study aims to see if this intervention is practical and acceptable to participants. You may be able to join if you are a young adult with cancer receiving or recently finished treatment at Massachusetts General Cancer Center, or if you are the partner of such an individual. This study plans to enroll 20 participants.

Study design
This is a single-arm pilot study involving 20 participants (10 young adults with cancer and 10 partners).
What's involved
You would participate in an eight-session intervention. You will also complete surveys at the beginning and end of the intervention, and may be invited for an optional interview.
Compensation
Not stated in the trial record.
Follow-up
Feasibility and acceptability of the intervention will be measured around 14 weeks after the start of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06172907

A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers

Recruiting
NAAges 25–39InterventionalSupportive care
Massachusetts General Hospital
~20 participants
Updated 2026-01-12 on ClinicalTrials.gov
What's tested:Young Adults Coping with Cancer Together Intervention

At a glance

Recruiting sites
4 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of Intervention
Measured over 14 +/- 2 Weeks
+1 more outcome measured

Conditions

Cancer
Survivorship
Caregiver Burden
Psychological Distress
Coping Skills
Couples

Explore related trials

Malignant Neoplasm

Where it's being run

4 sites across 1 states
Massachusetts4

Study leadership

  • Jamie M Jacobs, Ph.D. · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital
  • Giselle K Perez, Ph.D. · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital

Who to contact

Jamie M Jacobs, Ph.D.
[email protected]
617-643-1777
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Either: (1) Currently receiving active cancer treatment (n=5) or are within two years of completing active treatment (n=5) at Massachusetts General Cancer Center (MGHCC), located in Boston, Massachusetts, United States, OR (2) are the partner of an individual between the ages of 25-39 who is currently receiving treatment at MGHCC (n=5) or who has completed cancer treatment at MGHCC within the past two years (n=5)
Either: (1) Indicates a score ≥4 on the National Comprehensive Cancer Network (NCCN) adapted distress thermometer study screening questions, OR (2) are the partner of a participant indicating a score ≥4 on the NCCN adapted distress thermometer study screening questions
English-speaking

What this trial measures

  • Feasibility of Intervention14 +/- 2 Weeks

    Feasibility will be measured by measured by participant rates of enrollment (≥50% of those eligible), participant retention (≥70% of those enrolled), and intervention attendance (≥70% attending at least 6 of 8 sessions).

  • Acceptability of Intervention14 +/- 2 Weeks

    Acceptability with be measured by satisfaction with the intervention as rated on the Client Satisfaction Questionnaire. The intervention will be deemed acceptable if ≥75% of participants report average satisfaction that exceeds the CSQ's midpoint.